Top Pharmaceutical Companies in Toronto (58)
Cencora is a leading pharmaceutical solutions organization centered on improving the lives of people and animals everywhere. With 46,000+ global team members, we have the opportunity to make a positive impact on healthcare in communities everywhere. Our team members are empowered to activate their careers through a collective of tools and resources designed to support individual career interests and...
Cencora's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show steady top-line expansion: FY2025 rose 9.3% and FY2026 quarters continued to grow in the mid‑single digits, with full‑year guidance at 4%–6%. Management indicates both U.S. and International Healthcare Solutions are expected to expand, sustaining momentum.
Profitability: Adjusted operating income and EPS increased at double‑digit rates (e.g., FY2025 AOI +15.8% and EPS +16.3%, with Q3 FY2026 EPS +12%), and guidance points to 13%–14% adjusted operating income growth. Outlook also includes solid adjusted free cash flow of around $3.0B.
Strong Market Position & Advantage: The company is consistently portrayed as one of the three dominant U.S. pharmaceutical distributors, reflecting scale, reach, and entrenched relationships. This position supports durable volumes in specialty categories and international distribution.
Trinity Life Sciences is a modern partner to companies in the life sciences industry with nearly 30 years of expertise. The firm combines strategy, insights, and analytics to help life science executives with clinical and commercial decision-making. Serving over 300 pharmaceutical, biotech, and medical device clients, Trinity helps them develop the right drugs and devices for today’s market and optimize...
Piramal Group is an Indian multinational conglomerate with a presence across healthcare, life sciences, drug discovery, financial services, alternative investment, and real estate.
Canadian Mental Health Association (CMHA) Durham is a community primary care and mental health center providing advocacy, resources, and integrated care to support recovery and resilience in the Durham Region. Operating as an Integrated Health Hub, it offers a broad range of holistic services, including primary care, psychiatric care, supportive housing, and pharmaceutical care, to enhance the mental, emotional, and...
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company’s products and services are used for the therapy and care of critically and chronically ill patients. Its product portfolio comprises a range of highly complex biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs. Within biopharmaceuticals, Fresenius Kabi...
.jpeg)
Pillway is a tech-first, full-service virtual pharmacy that offers best-in-class service for individuals that require prescription medication, with a specialized focus for those who manage multiple medications per day. Reimagining the pharmacy experience, Pillway is revolutionizing today's traditional model through the thoughtful use of technology. It is the first of its kind in Canada that connects doctors, pharmacists and patients...
Centricity Research is an integrated research organization (IRO) with more than 40 wholly owned and integrated clinical research offices across North America. The company conducts Phase I-IV clinical research in over 35 therapeutic areas: inpatient and outpatient; pharmaceutical, biotechnology, and medical device trials. For more than 25 years, the organization’s founders have worked to revolutionize research by investing in the...
IPS-Integrated Project Services, LLC, a Berkshire Hathaway company, is a global leader in developing innovative solutions for the consulting, architecture, engineering, project controls, procurement, construction management, and CQV of technically complex facilities worldwide. With technical expertise spanning R&D to pilot-scale to large-scale production, our team specializes in the technology, trends, and regulatory environment to successfully deliver capital projects and improve...
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. We are powered...
Novo Nordisk's Top Stability & Growth Strengths
Strong Market Position & Advantage: Novo Nordisk is characterized as a global leader in GLP‑1–based diabetes and obesity care, anchored by clinically differentiated products like Wegovy and a broad GLP‑1 portfolio. While shares fluctuate by geography, disclosures and independent analyses continue to frame the company as a category leader.
Innovation-Driven Growth: Cardiovascular outcomes data supporting Wegovy’s label expansion and the first approved oral GLP‑1 for chronic weight management, together with late‑stage assets (e.g., amycretin/zenagamtide, CagriSema), strengthen adoption arguments and extend the franchise.
Market Expansion: U.S. launch momentum for the Wegovy pill, EU approval, and planned international rollouts in 2026 are broadening access and the addressable market. Significant capacity additions, including acquired fill‑finish sites and new investments, are intended to support higher volumes across regions.
Mednow is a Vancouver, British Columbia-based healthcare technology company and Canada's full-service online pharmacy. It operates a proprietary web and mobile application to facilitate the sale and distribution of prescription medications and provides fast advice from certified pharmacists through a digital-first environment, optimizing delivery through modern digital platforms and last-mile logistics.
For over 240 years, Takeda’s propensity to evolve has driven the next generation of innovation, and as a future-focused organization, we’re continuing to drive forward with endurance in our steadfast pursuit to achieve the best outcomes for our patients in a rapidly changing world. We have been preparing for this period of value creation by investing in data, digital and...
Takeda's Top Stability & Growth Strengths
Strong Market Position & Advantage: Takeda is consistently placed among the global top 15–20 by revenue and is a clear category leader in GI/IBD, plasma-derived therapies, and dengue vaccines with broad international authorizations and WHO support. Subcutaneous ENTYVIO and new oncology approvals like FRUZAQLA broaden real‑world use and extend reach.
Profitability: Reported FY2025 operating profit rose 19.3% year over year and EPS nearly doubled despite a slight revenue decline, supported by lower amortization and restructuring expense. Core profitability remained broadly stable as Growth & Launch Products expanded their share.
Future-Ready Strategy: Management is investing through FY2026 to convert a late‑stage pipeline (e.g., oveporexton, rusfertide, zasocitinib) into multiple launches, with Growth & Launch Products prioritized as near‑term engines. A multi‑year transformation and efficiency program targeting significant savings by FY2028 is intended to fund launches and strengthen competitiveness.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business...
Laurentis Energy Partners is a leader in the nuclear industry, providing end-to-end engineering and business solutions across the full nuclear life cycle, including design, maintenance, waste management, and decommissioning. They support a range of projects from small modular reactors to large-scale facilities and are a global supplier of critical medical radioisotopes used in cancer diagnosis and treatment, dedicated to harnessing...
Canada's online pharmacy ?? We make it easy to fill prescriptions ?, consult with pharmacists ?, and order medications online ?. #Pocketpills #PocketpillsPeople
Ashfield Advisory is a business unit that provides integrated advisory and consulting services to the healthcare industry, leveraging an ecosystem of specialized businesses for insight, strategy, and action.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ), is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are focused on developing life-changing medicines for people with serious diseases—often with limited or no options—so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give...
Jazz Pharmaceuticals, Inc's Top Stability & Growth Strengths
Strong Market Position & Advantage: Jazz is described as a clear leader in rare sleep disorders through its oxybate franchise (Xywav/Xyrem and authorized generics royalties) and in cannabinoid-based epilepsy with Epidiolex surpassing $1B in 2025. Xywav’s idiopathic hypersomnia approval with orphan exclusivity and category-leading revenue reinforce defensibility.
Strong Revenue Growth: Record 2025 revenue around $4.27 billion and a record Q4, with 2026 guidance still pointing up, indicate sustained top-line momentum. Company communications highlight a multi-year streak of annual growth continuing into 2026.
Diversified Revenue Streams: A balanced base with rare sleep revenues above $2B, Epidiolex above $1B, and roughly $1.13B in oncology plus new contributions from Modeyso and royalties shows multiple revenue pillars. Pipeline drivers like zanidatamab and Zepzelca label expansion add additional avenues.
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together...
Syneos Health's Top Stability & Growth Strengths
Strong Market Position & Advantage: Company materials and third‑party recognition portray a fully integrated CRO/CCO with leadership status, including widespread involvement in recent FDA/EMA novel therapies and recognition as a leading pharmacovigilance provider.
Strategic Partnerships: Recent collaborations with Microsoft and KX are positioned to enable AI‑driven efficiencies across clinical and commercial operations, with reported improvements in cycle times supporting operational scalability.
Investor Backing & Capital Strength: The 2025 take‑private by investment groups (including Elliott and Veritas) provides financial sponsorship to pursue tech‑enabled growth and operational repositioning.
Verity Pharmaceuticals is a specialty pharmaceutical company focused on commercializing therapeutically relevant prescription medicines, particularly those in short supply or absent from the healthcare environment.
University Health Network is Canada's largest research hospital and a public research and teaching hospital network in Toronto, Ontario, known for its scope of research and complexity of cases.
LMC Healthcare is Canada's largest specialist care provider in diabetes and endocrinology. The company transforms diabetes care by making it more accessible, comprehensive, and patient-centric. Operating 11 multi-disciplinary centers of excellence across Ontario and Alberta, LMC provides integrated services including endocrinology specialist practice, diabetes education, pharmacy, chiropody, optometry, and mental health services to over 77,000 patients annually.
